Search clinical trials for: Joint Position sense test (trunk)
Total 229 results
-
Astex Pharmaceuticals, Inc.UnknownPancreatic CancerUnited States
-
National Cancer Institute (NCI)SuspendedPathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 | Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 | Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8United States
-
Huashan HospitalShanghai 10th People's Hospital; Shanghai East Hospital; Zhejiang University; The... and other collaboratorsCompleted
-
Charles S. Grob, M.D.University of California, San FranciscoNot yet recruiting
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedDiffuse Large B-Cell LymphomaBelgium
-
XiaoYong LiuRecruitingCytomegalovirus Infections | Ocular Myasthenia GravisChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingThyroid Gland Follicular Carcinoma | Thyroid Gland Papillary Carcinoma | Thyroid Gland Oncocytic CarcinomaUnited States
-
Shenzhen People's HospitalNot yet recruitingHypertensive EmergencyChina
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid CancerUnited States
-
Indiana UniversityHALEONCompleted
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMulticenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy (PSMA SRT)Recurrent Prostate CarcinomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Freeman-Sheldon Research Group, Inc.TerminatedDepressive Disorder | Craniofacial Abnormalities | Posttraumatic Stress Disorder | ArthrogryposisUnited States, Guatemala
-
University Hospital, GenevaCompleted
-
University of BirminghamAcerta Pharma, LLC; BloodwiseRecruitingRichter SyndromeUnited Kingdom
-
Dar El Oyoun HospitalUnknownCataract | Adverse Drug Event | MydriasisEgypt
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
Hacettepe UniversityCompletedQuality of Life | Physical Disability | Psychosocial Problem | Meniere DiseaseTurkey
-
National Cancer Institute (NCI)SuspendedPrimary Diffuse Large B-Cell Lymphoma of the Central Nervous SystemUnited States
-
Children's Oncology GroupNot yet recruitingStage I Kidney Wilms Tumor | Stage II Kidney Wilms Tumor | Stage III Kidney Wilms Tumor | Stage IV Kidney Wilms Tumor
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditionsUnited States, Puerto Rico
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...Completed
-
Henry Ford Health SystemRecruitingShoulder Pain | Shoulder ArthropathyUnited States
-
British Columbia Cancer AgencyHoffmann-La RocheActive, not recruitingLymphoma, Non-Hodgkin | Advanced Stage Diffuse Large B-Cell Non-Hodgkin's LymphomaCanada
-
National Cancer Institute (NCI)WithdrawnT Acute Lymphoblastic Leukemia | T Lymphoblastic Lymphoma
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Ganglioneuroblastoma, NodularUnited States, Australia, Canada, New Zealand
-
University of WashingtonNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States